<DOC>
	<DOCNO>NCT00985387</DOCNO>
	<brief_summary>The purpose study assess patient 's persistency maintain solifenacin treatment overactive bladder .</brief_summary>
	<brief_title>Evaluation Adherence Solifenacin Treatment Overactive Bladder Patients</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Overactive bladder symptom last 3 month The question 3 score overactive bladder symptom score ( OABSS ) ≥ 2 sum score OABSS ≥ 3 Symptoms urinary urgency define level 1 2 3point Urgency Perception Scale ( UPS ) Any condition would contraindicate usage anticholinergic treatment , include : urinary retention , gastric retention , uncontrolled narrow angle glaucoma , myasthenia gravis Symptomatic acute urinary tract infection ( UTI ) Diagnosed suspect interstitial cystitis Treatment anticholinergic drug 3 month within 12 month prior study Pregnant nursing woman Treatment within 14 day study expect initiate treatment study anticholinergic drug solifenacin treatment overactive bladder drug Any condition , opinion investigator , make patient unsuitable inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>persistency treatment</keyword>
	<keyword>Vesicare</keyword>
</DOC>